UChicago Medicine Faculty Physicians
Rohini Chakravarthy, MD, MPH
Rohini Chakravarthy, MD, MPH
UChicago Medicine Faculty Physicians
Assistant Professor of Pediatrics
Specialties
- Pediatric Hematology & Oncology (Pediatric Cancer)
Locations
- Chicago - Comer Children's Hospital
- About
- Specialties & Areas of Expertise
- Locations & Patient Information
- Education & Research
- Accepted Insurance
- External Professional Relationships
[AUDIO LOGO] My name is Doctor Rohini Chakravarthy, and I am a pediatric bone marrow transplant doctor. So that means I take care of patients with a variety of different diagnoses, like cancer diagnoses, or sickle cell disease, a variety of different immune disorders, et cetera, and really take them through the transplant process. So I love Comer because I love that everybody here is invested in taking care of the patients, from providing the resources that they need, getting creative when we need to in order to get our patients the care that they need, everyone is invested in really caring for our patients, and that's really what I love about working here. I also focus a lot of my research efforts on understanding the long-term effects of our therapies. So really trying to make sure that we are providing patients with the best evidence-based therapies that are out there, but also trying to minimize the long-term complications from the treatments that we give them. My goal in taking care of a patient is to really be able to take care of the patient as a whole. So various different mentors that I've worked with from training have really taught me how to not just treat the diagnosis, but really treat the patient in front of you. And that involves understanding what's important to them, what their needs are, what their goals are, and really trying to tailor your treatment and the care that you provide to what they need in order to make sure that not only are we helping them treat the disease that they have, but also making sure that we are giving them the best quality of life. [AUDIO LOGO]
Rohini Chakravarthy, MD, MPH, is a dedicated pediatric oncologist. Dr. Chakravarthy brings extensive expertise in the diagnosis and treatment of cancers and blood disorders in children, such as leukemias, lymphomas and solid tumors. She is passionate about improving the lives of her young patients through advanced medical care.
With expertise in stem cell transplant and cellular therapy, Dr. Chakravarthy focuses on the use of transplant and cellular therapies to treat malignant disorders. By integrating the latest research findings into her practice, she ensures that her patients receive the most effective, up-to-date, evidence-based treatments available.
In her approach to patient care, Dr. Chakravarthy emphasizes compassionate and individualized treatment plans. She believes that every patient has a unique story. By striving to build relationships, developing trust and open communication, her goal is to provide comprehensive care that addresses the physical, social and emotional symptoms that affects her young patients and their families. She hopes to ensure that each patient and family is supported through their journey.
Dr. Chakravarthy’s research focuses on long-term effects of cancer and transplant therapies with a particular interest in reproductive health and fertility. She hopes to continue to find innovate therapies that effective in curing disease but also have fewer long-term toxicities.
With expertise in stem cell transplant and cellular therapy, Dr. Chakravarthy focuses on the use of transplant and cellular therapies to treat malignant disorders. By integrating the latest research findings into her practice, she ensures that her patients receive the most effective, up-to-date, evidence-based treatments available.
In her approach to patient care, Dr. Chakravarthy emphasizes compassionate and individualized treatment plans. She believes that every patient has a unique story. By striving to build relationships, developing trust and open communication, her goal is to provide comprehensive care that addresses the physical, social and emotional symptoms that affects her young patients and their families. She hopes to ensure that each patient and family is supported through their journey.
Dr. Chakravarthy’s research focuses on long-term effects of cancer and transplant therapies with a particular interest in reproductive health and fertility. She hopes to continue to find innovate therapies that effective in curing disease but also have fewer long-term toxicities.
Areas of Expertise
- Pediatric Stem Cell Transplant
- Cellular Therapy
- Leukemia
- Lymphoma
- Solid Tumors in Children
Board Certifications
- Pediatric Hematology and Oncology
- Pediatrics
Languages Spoken
- English
- Tamil
Medical Education
- University of Kansas School of Medicine
Internship
- Medical College of Wisconsin Affiliated Hospitals/Childrenâs Wisconsin
Residency
- Medical College of Wisconsin Affiliated Hospitals/Children's Wisconsin
Fellowship
- University of Colorado/Childrenâs Hospital Colorado; Vanderbilt University Medical Center
News & Research
Insurance
- Aetna Better Health *see insurance page
- Aetna HMO (specialists only)
- Aetna Medicare Advantage HMO & PPO
- Aetna POS
- Aetna PPO
- BCBS Blue Precision HMO (specialists only)
- BCBS HMO (HMOI) (specialists only)
- BCBS Medicare Advantage HMO & PPO
- BCBS PPO
- Cigna HMO
- Cigna POS
- Cigna PPO
- CountyCare *see insurance page
- Humana Medicare Advantage Choice PPO
- Humana Medicare Advantage Gold Choice PFFS
- Humana Medicare Advantage Gold Plus HMO
- Medicare
- Multiplan PPO
- PHCS PPO
- United Choice Plus POS/PPO
- United Choice HMO (specialists only)
- United Options (PPO)
- United Select (HMO & EPO) (specialists only)
- United W500 Emergent Wrap
- University of Chicago Health Plan (UCHP)
Our list of accepted insurance providers is subject to change at any time. You should contact your insurance company to confirm UChicago Medicine participates in their network before scheduling your appointment. If you have questions regarding your insurance benefits at UChicago Medicine, please contact our financial counseling team at OPSFinancialCounseling@uchospitals.edu.
UChicago Medicine is committed to fostering a corporate culture of ethical behavior and integrity in all matters related to compliance with the laws and regulations that govern the delivery of healthcare. This aspiration is central to supporting patient care, research, and teaching at UChicago Medicine.
Some of our physicians and health professionals collaborate with external pharmaceutical, medical device, or other medical related entities to develop new treatments and products to improve clinical outcomes for patients. In some instances, the physician has ownership interests in the external entity and/or is compensated for advising or speaking about the entity’s products or treatments. These payments may include compensation for consulting and speaking engagements, equity, and/or royalties for products invented by our physicians. To assure objectivity and integrity in patient care, UChicago Medicine requires all physicians and health professionals to report their relationships and financial interests with external entities on an annual basis. This information is used to review relationships and transactions that might give rise to potential financial conflicts of interest, and when considered to be significant a management plan to mitigate any biases is created.
If you are a patient at UChicago Medicine and would like more information about your physician’s external relationships, please talk with your physician. You may also visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website at https://openpaymentsdata.cms.gov/ . CMS Open Payments is a national disclosure program that promotes a more transparent and accountable health care system. It houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and hospitals.
Information in the CMS Open Payments database could potentially contain inaccurately reported and out of date payment information. All information is open to personal interpretation, if there are questions about the data, patients and their advocates should speak directly to their health care provider for a better understanding.
Some of our physicians and health professionals collaborate with external pharmaceutical, medical device, or other medical related entities to develop new treatments and products to improve clinical outcomes for patients. In some instances, the physician has ownership interests in the external entity and/or is compensated for advising or speaking about the entity’s products or treatments. These payments may include compensation for consulting and speaking engagements, equity, and/or royalties for products invented by our physicians. To assure objectivity and integrity in patient care, UChicago Medicine requires all physicians and health professionals to report their relationships and financial interests with external entities on an annual basis. This information is used to review relationships and transactions that might give rise to potential financial conflicts of interest, and when considered to be significant a management plan to mitigate any biases is created.
If you are a patient at UChicago Medicine and would like more information about your physician’s external relationships, please talk with your physician. You may also visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website at https://openpaymentsdata.cms.gov/ . CMS Open Payments is a national disclosure program that promotes a more transparent and accountable health care system. It houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and hospitals.
Information in the CMS Open Payments database could potentially contain inaccurately reported and out of date payment information. All information is open to personal interpretation, if there are questions about the data, patients and their advocates should speak directly to their health care provider for a better understanding.